INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees

Clinical trial NCT04906629 · COMPLETED

Trial details

NCT number: NCT04906629
Sponsor: University of Geneva, Switzerland
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2021-09-01
Primary completion: 2022-01-05
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.